Sponsor content
46 result(s) found, displaying 31 to 40
-
Australian Public Assessment Report (AusPAR)AusPAR for SPIKEVAX COVID-19 VACCINE (elasomeran) as booster in 12 to 17 years of age for prevention of COVID-19
-
Designation or determinationProvisional determination
-
Prescription medicine decision summarySpikevax Bivalent Original/Omicron (elasomeran and imelasomeran) was approved for the prevention of COVID-19.
-
Australian Public Assessment Report (AusPAR)SPIKEVAX BIVALENT ORIGINAL/OMICRON - (elasomeran and imelasomer) for prevention of COVID-19
-
Prescription medicine registrationActive ingredients: elasomeran, imelasomeran.
-
Australian Public Assessment Report (AusPAR)Spikevax (elasomeran) for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older
-
Prescription medicine registrationActive ingredients: elasomeran.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Elasomeran
-
Prescription medicine registrationActive ingredients: elasomeran.
-
Prescription medicine registrationActive ingredients: elasomeran.